CREATING TOMORROW'S SOLUTIONS

WACKER - Accelerating Proven Successes

Wacker Chemie AG

August 2023

Disclaimer

The information contained in this presentation is for background purposes only and is subject to amendment, revision, and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties. In addition to statements that are forward-looking because of context, including without limitation, statements referring to risk limitations, operational profitability, financial strength, performance targets, profitable growth opportunities, and risk adequate pricing, other words such as "may, will, should, expects, plans, intends, anticipates, believes, estimates, predicts, or continue," "potential, future, or further," and similar expressions identify forward-looking statements. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These include, among other factors, changing business or other market conditions and the prospects for growth anticipated by the Company's management. These and other factors could adversely affect the outcome and financial effects of the plans and events described herein. Statements contained in this presentation regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any statements in this presentation, whether as a result of new information, future events, or otherwise. In particular, you should not place undue reliance on forward-looking statements, which speak only as of the date of this presentation.

Front page:

BIOSOLUTIONS: FERMOPURE® - plant-basedL-cystine and L-cysteine, 100% vegetarian flavors ideal for serving the growing demand for foods without animal ingredients

@Wacker Chemie AG

1

August 2023

WACKER: At a Glance

Facts & Figures

€8.21bn

15,725

Sales in 2022

Employees

€2.09bn

27

EBITDA in 2022

Production Sites

25.4%

26

EBITDA margin

Technical Centers

in 2022

Business

Scientific

4 Segments

45 collaborations

POLYSILICONSILICONES

No. 1 in semi

No. 2

Sales

FY 2022

POLYMERS

No. 1

BIOSOLUTIONS

OTHERS

Leading in niches

@Wacker Chemie AG

2

August 2023

A New Phase with New Group Targets for 2030

Faster Growth, Bolder Moves, High Profitability

  • SALES: >€10bn
  • EBITDA Margin: >20%
  • VOLUME/MIX CAGR: 1.5 - 2x historic
  • ROCE: 2x Cost of Capital

Strategic Growth Projects

  • SILICONES: Specialties
  • POLYMERS: Tandems (VAE+DPP)
  • BIOSOLUTIONS: Biologics
  • POLYSILICON: Semi

Chemicals Financial KPIs

35%

€1,165m

27%

19%

€710m

€440m

21%

19%

€294m

15%

13%

2012-16

2017-21

2022

H1/23

Chemicals EBITDA / Margin (5 year avg.) Chemicals ROCE

@Wacker Chemie AG

3

August 2023

Ambitious Sustainability Targets for 2030

Value Up

100% Productscriteria meet sustainability

Footprint Down

50%

Reduction in absolute GHG1

emissions (vs. 2020)

15%

Reduction in specific water

withdrawal (vs. 2020)

15%

Reduction in specific energy

consumption (vs. 2020)

0

Accidents

Collaboration Beyond

Key suppliers meet

100% sustainability standards

25%

Reduction in absolute

upstream GHG emissions

(vs. 2020)

Extend World-class "Verbund" sites and circular economy

Clear Commitment to 1.5°C Paris Agreement

Net

Zero

1) GHG = Greenhouse gas

@Wacker Chemie AG

4

August 2023

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Wacker Chemie AG published this content on 31 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 July 2023 08:23:05 UTC.